Jay D Keasling

This inventor holds 78 USPTO granted patents and 38 published patent applications, plus 6 CIPO patents and 12 EPO patents, primarily in Synthetic Biology (CPC class C12N). Top assignees: University of California, The United States of America as Represented by the Department of Energy, Amyris Biotechnologies, Inc.. Active years: 2000-2026.

USPTO Granted Patents = 78 (Patent Applications = 38)

% Patents Active = 66.7

CIPO Patents = 6 (Patent Applications = 4)

EPO Patents = 12 (Patent Applications = 22)

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 460(Granted Patents)

Forward Citations (Not Self Cited) = 402(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

73 out of 15,964

University of California

patents

2 out of 1,211

The United States of America as Represented by the Department of Energy

patents

1 out of 18

Amyris Biotechnologies, Inc.

Geomatrix Consultants, Inc.

National Technology & Engineering Solutions of Sandia, LLC

patents

8. 1 out of 4

Pacific Northwest National Laboratory

patents

9. 1 out of 29

Reg Life Sciences, LLC

patents

where one patent can have more than one assignee

Years Active: 2000-2026

Loading Chart...

Areas of Expertise:

Synthetic Biology

Cannabinoids

Fatty Alcohols

Polyketide Synthases

Genetically Modified Microorganisms

Terpenoids

Bioproducts

Lignin-Derived Aromatics

Host Cells

Metabolic Engineering

Fusion Proteins

Diacid Compounds

78 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12680114 - Cyclopropane-containing compounds useful as fuel (2026-07-14),

2. 12331302 - Fungal autoinducible expression system (2025-06-17),

3. 12215327 - Microorganisms and methods for producing cannabinoids and cannabinoid derivatives (2025-02-04),

4. 12188073 - Yeast cells and methods for producing fatty alcohols (2025-01-07),

5. 12129493 - Host cells and methods useful for producing unnatural terpenoids using a novel artificial metalloenzyme (2024-10-29),

6. 11746336 - Producing 3-hydroxycarboxylic acid and ketone using polyketide synthases (2023-09-05),

7. 11542512 - Microorganisms and methods for producing cannabinoids and cannabinoid derivatives (2023-01-03),

8. 11505810 - Host cells and methods for producing alkyl lactone by cyclization of hydroxyl fatty acid (2022-11-22),

9. 11505791 - Hybrid polyketide synthases (2022-11-22),

10. 11384367 - Synthesis of bioproducts from lignin-derived aromatics by genetically modified microorganisms (2022-07-12),

11. 11365431 - Yeast cells and methods for producing fatty alcohols (2022-06-21),

12. 11046981 - Host cell modified to produce lactams (2021-06-29),

13. 11021525 - Synthetic transcription factor and uses thereof (2021-06-01),

14. 10975379 - Methods for producing cannabinoids and cannabinoid derivatives (2021-04-13),

15. 10876139 - Host cells and methods for producing diacid compounds (2020-12-29),

Title: A Spotlight on Renowned Inventor Jay D. Keasling

Introduction:

Jay D. Keasling, a distinguished inventor based in Berkeley, CA, is known for his groundbreaking work in the field of biotechnology. With an impressive portfolio of 73 patents, Keasling continues to push the boundaries of innovation in the scientific community.

Latest Patents:

Keasling's latest patents showcase his expertise in bioengineering and synthetic biology. One notable invention is the development of a polyketide synthase (PKS) capable of synthesizing 3-hydroxycarboxylic acid and ketone, offering new possibilities for chemical synthesis. Additionally, his work on genetically modified host cells for producing cannabinoids and cannabinoid derivatives highlights his commitment to advancing pharmaceutical research.

Career Highlights:

Throughout his career, Keasling has made significant contributions to various organizations, including the prestigious University of California and Ls9, Inc. His role in these institutions has been pivotal in driving forward innovative research projects that have the potential to revolutionize multiple industries.

Collaborations:

Keasling's collaborative efforts with esteemed colleagues like Jack Newman and Douglas J. Pitera have been instrumental in the success of many projects. By working closely with fellow experts in the field, Keasling has been able to leverage diverse perspectives and expertise, leading to groundbreaking discoveries.

Conclusion:

In conclusion, Jay D. Keasling's remarkable journey as an inventor exemplifies the transformative power of innovation and dedication. His pioneering work in biotechnology continues to inspire future generations of inventors and researchers, shaping the landscape of scientific discovery for years to come.